Jennifer Martin

Reducing Inappropriate Polypharmacy

Ian Scott, Sarah N. Hilmer, Emily Reeve et al. · JAMA Internal Medicine · 2015 · 1.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats

J. Andrew Pospisilik, Jennifer Martin, Timothy Doty et al. · Diabetes · 2003 · 334 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Therapeutic drug monitoring of antimicrobials

Jason A. Roberts, Ross Norris, David L. Paterson et al. · British Journal of Clinical Pharmacology · 2011 · 312 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

Veronique Chachay, Graeme A. Macdonald, Jennifer Martin et al. · Clinical Gastroenterology and Hepatology · 2014 · 284 citations · Full text

Medicine, Biochemistry, Pharmacotherapy +9

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study

Paola Nicoletti, Guruprasad P. Aithal, Einar S. Björnsson et al. · Gastroenterology · 2016 · 221 citations · Full text

Life Sciences, Genetics, Pharmacology +13